Ralph Snyderman

Dr. Snyderman is Chancellor Emeritus at Duke University and James B. Duke Professor of Medicine. He served as Chancellor for Health Affairs and Dean of the School of Medicine from 1989 to 2004. He oversaw the development of the Duke University Health System, one of the most successful integrated health systems in the country and served as its first CEO and President. He was also a prominent researcher in the field of inflammation and has won many awards for his seminal work on leukocyte chemotaxis. In 1987, Dr. Snyderman joined Genentech, Inc. as vice president for medical research and development where he led the development and licensing of important therapeutics and supervised 300 staff members working in pharmacology, clinical research and regulatory affairs. He served on the board of Proctor and Gamble and led its Innovation and Technology Committee. He has been called “the father of personalized medicine” by the Association of American Medical Colleges. Dr. Snyderman has authored nearly 400 manuscripts and numerous books and is a member of the Institute of Medicine and the American Academy of Arts & Sciences.